DAVID PISON: Open Payments
NPI 1487183430 · LEBANON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 5 payments from 5 companies in 2025. Trend: 2023 $509 · 2024 $302 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $117 |
| Janssen Pharmaceuticals, Inc | 1 | $85 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: Auvelity, COBENFY, UZEDY, SPRAVATO, INGREZZA.
Industry payments across IN — which companies pay providers there.
